Community Center

ATTR-CM: A Care Partner’s Perspective

Apr 07, 2026

Amyloidosis: Navigating Uncertainty in ATTR Amyloidosis: Clinical Judgment and Shared Decisions.

Apr 06, 2026

jacknicklaus

Apr 06, 2026

The one cause of heart failure that still gets missed too-often.

Apr 05, 2026

Amyloidosis Foundation

Apr 04, 2026

Most people have never come across the word amyloidosis and that’s part of the problem.

Mar 31, 2026

This #AmyloidosisAwarenessMonth, we’re honored to share Anne Marie and Gesna’s perspectives on the progress made in the amyloidosis

Mar 24, 2026

Amyloidosis Awareness Month

Mar 24, 2026

Amyloidosis Awareness

Mar 21, 2026

Amyloidosis Awareness

Mar 18, 2026

Cardiac amyloidosis

Subscribe to

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Learn More

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion